Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 28;23(2):61-65.
doi: 10.1016/j.jpge.2016.02.005. eCollection 2016 Mar-Apr.

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block

Isabel A Hujoel  1 , Alberto Rubio-Tapia  1   2
Affiliations

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block

Isabel A Hujoel et al. GE Port J Gastroenterol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed Management for Patients with Sprue-like Enteropathy associated with Olmesartan. 1. Differential diagnosis includes (but it is not limited to) seronegative celiac disease, other drug-related enteropathies, autoimmune enteropathy, tropical sprue, small-bowel bacterial overgrowth, hypogammaglobulinemic sprue, Giardiasis, refractory celiac disease, Whipple's disease, collagenous sprue, and unclassified sprue. 2. If there is a need for continuation of alternative therapy, we recommend to use a different class of medication whenever is clinically possible.
See this image and copyright information in PMC

References

    1. Rubio-Tapia A., Herman M.L., Ludvigsson J.F., Kelly D.G., Mangan T.F., Wuet T. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87:732–738. - PMC - PubMed
    1. Greywoode R., Braunstein E.D., Arguelles-Grande C., Green P.H., Lebwohl B. Olemsartan, other anti-hypertensives, and chronic diarrhea among patients undergoing endoscopic procedures: a case-control study. Mayo Clin Proc. 2014;89:1239–1243. - PMC - PubMed
    1. Esteve M., Temiño R., Carrasco A., Batista L., Del Val A., Blé M. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: a population-based study. Dig Liver Dis. 2016;48:154–161. - PubMed
    1. Sentinel M. Angiotensin II Receptor Blockers and Celiac Disease. Available from: http://www.mini-sentinel.org/work_products/Assessments/Mini-Sentinel_Ang... [cited 6.02.16].
    1. Marthey L., Cadiot G., Seksik P., Pouderoux P., Lacroute J., Skinazi F. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther. 2014;40:1103–1109. - PubMed

LinkOut - more resources